Moody's Affirms Bupa's Rating

Summary by AI BETAClose X

Moody's Ratings has affirmed Bupa's A1 Insurance Financial Strength Rating for its UK private medical insurance business and Bupa Global Designated Activity Company, maintaining a stable outlook for all entities. Additionally, the ratings agency affirmed Bupa Finance Plc's A3 backed senior unsecured, Baa1(hyb) subordinated, and Baa3(hyb) preferred stock non-cumulative debt ratings, also with a stable outlook.

Disclaimer*

BUPA Finance PLC
20 May 2026
 

RNS

 

LEI Number: ZIMCVQHUFZ8GVHENP290

 

20 May 2026

 

Moody's Ratings affirms Bupa's A1 Insurance Financial Strength Rating; outlook stable

 

Moody's Ratings ('Moody's') today has affirmed the A1 Insurance Financial Strength Ratings of Bupa Insurance Ltd, the main UK private medical insurance business of the wider Bupa Group ('Bupa' or 'group'), and group subsidiary Bupa Global Designated Activity Company.

 

Moody's have also affirmed the A3 backed senior unsecured, Baa1(hyb) subordinated and Baa3(hyb) preferred stock non-cumulative debt ratings of Bupa Finance Plc.

 

The outlook on all entities remains stable.

 

See the full announcement from Moody's here.

 

 

Enquiries

 

Media: Duncan West (Corporate Affairs): duncan.west@bupa.com

Investors: Gareth Evans (Group Treasury): ir@bupa.com

 

About Bupa

 

Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving 68 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia.

 

For more information, visit www.bupa.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings